January 2016 PMID 25911072

National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report.

Terry A Jacobson, Matthew K Ito, Kevin C Maki, Carl E Orringer, Harold E Bays, Peter H Jones, James M McKenney, Scott M Grundy, Edward A Gill, Robert A Wild, Don P Wilson, W Virgil Brown

Full text PDF Download social card

Mentions

Peak: 1 in Feb 2019

across 4 sources since Feb 2019

Extended reach

60,692

potential audience

Total likes

6,640

Video views

54,410

Mentions per month

Feb 2019 – Mar 2025

Where it's discussed

News6 articles
X / Twitter3 posts
YouTube2 videos
Facebook2 posts

AI synopsis

What people are saying

The group of discussions reflects a generally positive consensus about the publication's clinical relevance, with users referencing the importance of lipid management, personalized therapies, and the integration of risk factors. The tone suggests that these guidelines are seen as valuable tools for improving cardiovascular outcomes, demonstrated by phrases like 'key to patient care' and 'must adopt for better management.' The detailed references to specific parts of the report and clinical strategies indicate a high level of engagement and interest.

AgreementModerate agreement

Most discussions align with the report’s emphasis on personalized treatment and the importance of lowering lipids to reduce cardiovascular risk.

InterestModerate interest

Posters show moderate interest by engaging with specific recommendations and citing relevant guidelines.

EngagementHigh engagement

Many posts delve into details, referencing the importance of statins, risk assessment, and managing other risk factors.

ImpactModerate impact

The discussions highlight the potential influence of these guidelines on clinical practice and patient management.

Abstract in brief

The report emphasizes that high levels of atherogenic cholesterol, such as non-HDL-C and LDL-C, are key causes of atherosclerosis and cardiovascular disease, and lowering these levels reduces risk.
Risk-reduction therapies should be personalized based on an individual’s overall risk for ASCVD, considering both short-term and lifetime risk, with statins being the primary treatment for lipid lowering.
Managing other risk factors like high blood pressure, smoking, and diabetes, along with regular monitoring of cholesterol levels, is essential for effective prevention of cardiovascular disease.]

Read the full abstract

All mentions

Carnivore Diet Study: Health Implications and Risks

The video discusses the effects of a carnivore diet, referencing studies on saturated fats, cholesterol, and cardiovascular risk factors, highlighting potential health benefits and concerns.

Nunca vi 1 cientista · Feb 28, 2025 53,936 views

Impact of Dietary Fats and Cholesterol Management on Cardiovascular Health

Join the live session discussing how reducing saturated fat and managing cholesterol levels can improve cardiovascular health, supported by scientific research and expert insights.

Shaolin - Verdade ou Mentira · Mar 25, 2025 474 views

Terry Simpson

@terrysimpson · X

Oct 1, 2024 · 2 likes · 6,247 followers View post →

DrAlvaroBustamante

@DrAlvaroBustam · X

3) T. A. Jacobson et al. ´National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2`. J Clin Lipidol. 2015, S1-122.e1.

Aug 13, 2024 · 30 followers View post →

ibina abigo

@AbigoIbina · X

National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary DOI:10.1016/j.jacl.2014.07.007

Feb 3, 2019 · 6 followers View post →